Ken Griffin Cronos Group Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.08 - $2.49 $27,456 - $32,868	-13,200 Reduced 8.29%	146,000 $321,000
Q2 2024 Aug 14, 2024	SELL	$2.27 - $3.02 $180,692 - $240,392	-79,600 Reduced 33.33%	159,200 $370,000
Q1 2024 May 15, 2024	BUY	$1.93 - $2.7 $166,173 - $232,470	86,100 Added 56.39%	238,800 $623,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $2.19 $26,488 - $33,726	-15,400 Reduced 9.16%	152,700 $319,000
Q3 2023 Nov 14, 2023	SELL	$1.68 - $2.47 $180,936 - $266,019	-107,700 Reduced 39.05%	168,100 $336,000
Q2 2023 Aug 14, 2023	SELL	$1.67 - $2.04 $186,205 - $227,460	-111,500 Reduced 28.79%	275,800 $543,000
Q1 2023 May 15, 2023	SELL	$1.87 - $2.6 $1.22 Million - $1.69 Million	-651,000 Reduced 62.7%	387,300 $751,000
Q4 2022 Feb 14, 2023	BUY	$2.49 - $3.5 $1.76 Million - $2.47 Million	705,600 Added 212.08%	1,038,300 $2.64 Million
Q3 2022 Nov 14, 2022	SELL	$2.82 - $3.58 $133,950 - $170,050	-47,500 Reduced 12.49%	332,700 $938,000

210

47.5M

3.38M

1.6M

Ticker CRON
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 377,896,000
Market Cap $760M
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.